Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Oral contraceptives and the risk of ductal breast carcinoma in situ.

Oral contraceptives and the risk of ductal breast carcinoma in situ. Breast Cancer Res Treat. 2003 Sep; 81(2):129-36.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.